How do serum lipid levels change and influence progression-free survival in epithelial ovarian cancer patients receiving bevacizumab treatment?

BACKGROUND: This study aimed to investigate how serum lipid levels affect epithelial ovarian cancer (EOC) patients receiving bevacizumab treatment and to develop a model for predicting the patients’ prognosis. METHODS: A total of 139 EOC patients receiving bevacizumab treatment were involved in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoyu, Huang, Yong, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090393/
https://www.ncbi.nlm.nih.gov/pubmed/37064140
http://dx.doi.org/10.3389/fonc.2023.1168996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090393/
https://www.ncbi.nlm.nih.gov/pubmed/37064140
http://dx.doi.org/10.3389/fonc.2023.1168996

Ejemplares similares